Biotech investors in France
Updated 16 Nov 2026
Venture funds
4 funds, by portfolio companies funded in the last 12 months| # | Fund | Sectors | Stages | Leads | Funded, 12 months |
|---|---|---|---|---|---|
| 1 | Sofinnova Partners Sofinnova Partners invests in life sciences from seed to later stage, including T-Therapeutics, Mironid and DISCO Pharmaceuticals. Paris, France |
Biotech, Health care | Seed, Early stage venture, Late stage venture | 44% | 4 |
| 2 | Breakthrough Energy Ventures Breakthrough Energy Ventures targets reliable, affordable power without climate impact, recently backing Type One Energy and Antora Energy. Paris, France |
Energy, Artificial intelligence | Seed, Early stage venture, Late stage venture | 43% | 2 |
| 3 | Andera Partners Andera Partners makes early- and late-stage venture investments, with recent companies including Kainova Therapeutics and Exciva. Paris, France |
Biotech, Health care | Early stage venture, Late stage venture | 40% | 2 |
| 4 | Seventure Partners Seventure Partners targets Tech/Digital and Life Sciences companies, with recent companies including Microbiotica and Standing Ovation. Paris, France |
Biotech, Health care | Seed, Early stage venture, Late stage venture | 36% | 2 |
Table 1. Biotech investors in France: venture capital and micro VC funds ranked by biotech companies whose most recent round closed in the last 12 months. Leads is the share of all recorded investments where the fund was lead investor. Source: FundingWatcher. Data as of 16 November 2026.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.
| Investor | Type | Location | Phone | |
|---|---|---|---|---|
| Bpifrance | Government investment office | Maisons-alfort, France | •••@bpifrance.fr | +33 (0••• |
| Sofinnova Partners | Venture capital firm | Paris, France | •••@sofinnovapartners.com | +33 (0••• |
| Andera Partners | Private equity firm | Paris, France | •••@bper.ch | 58 818••• |
| Seventure Partners | Venture capital firm | Paris, France | •••@seventure.fr | +33 1-••• |
| Kurma Partners | Venture capital firm | Paris, France | •••@kurmapartners.com | +33184••• |
| Eurazeo | Private equity firm | Paris, France | •••@eurazeo.com | +33 0 ••• |
| Elaia | Venture capital firm | Paris, France | •••@elaia.com | +33 1 ••• |
| Omnes Capital | Private equity firm | Paris, France | •••@omnescapital.com | +33018••• |
8 rows of the CSV in 5 of its 15 columns, email and phone masked.
- 19 of the 23 biotech investors in France have a published email address, 17 a phone number and 23 a website.
- Bpifrance has the most recorded investments, 1,680, 454 of them as lead investor.
- 16 of them are investors in at least one company that closed its most recent round in the last 12 months.
- Bpifrance is an investor in 19 of those companies, more than any other investor on this list.
- The newest round among their portfolio companies is T-Therapeutics' $133.0M Series B on 5 November 2026.
- Software is the most common sector across their 1,134 portfolio companies (74%).
- Early stage venture is the most common investment stage, recorded for 21 of them (91%).
Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.
Biotech investors in France
23 of 23, most investments first| # | Investor | Type | Location | Invests in | Latest portfolio companies | Funded, 12 months | Investments | Lead | Exits | Phone | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Bpifrance | Government investment office, Investment bank | Maisons-alfort, France | Artificial intelligence, Hardware | WORMSENSING, CarbonFarm Technology, Archeon | 19 | 1,680 | 454 | 214 | •••@bpifrance.fr | +33 (0••• | In the CSV |
| 2 | Sofinnova Partners | Venture capital firm | Paris, France | Biotech, Health care | T-Therapeutics, Mironid, Bon Vivant | 5 | 373 | 164 | 76 | •••@sofinnovapartners.com | +33 (0••• | In the CSV |
| 3 | Andera Partners | Private equity firm, Venture capital firm | Paris, France | Biotech, Health care | Kainova Therapeutics, Exciva | 2 | 214 | 85 | 69 | •••@bper.ch | 58 818••• | In the CSV |
| 4 | Seventure Partners | Venture capital firm | Paris, France | Biotech, Health care | Microbiotica, Standing Ovation | 2 | 300 | 109 | 75 | •••@seventure.fr | +33 1-••• | In the CSV |
| 5 | Kurma Partners | Venture capital firm | Paris, France | Health care, Biotech | Tacalyx | 1 | 131 | 65 | 18 | •••@kurmapartners.com | +33184••• | In the CSV |
| 6 | Eurazeo | Private equity firm | Paris, France | Artificial intelligence, Health care | Olyzon, Kohort, Vertical Compute | 4 | 344 | 150 | 77 | •••@eurazeo.com | +33 0 ••• | In the CSV |
| 7 | Elaia | Venture capital firm | Paris, France | Artificial intelligence, Hardware | Alice & Bob, MyC, Sim&Cure | 4 | 225 | 102 | 52 | •••@elaia.com | +33 1 ••• | In the CSV |
| 8 | Kima Ventures | Micro VC fund | Paris, France | Fintech, Artificial intelligence | Topo.io, Rayon, Kelvin | 16 | 915 | 65 | 142 | In the CSV | ||
| 9 | Omnes Capital | Private equity firm, Venture capital firm | Paris, France | Hardware, Cybersecurity | WhiteLab Genomics, BIZAY | 2 | 264 | 59 | 96 | •••@omnescapital.com | +33018••• | In the CSV |
| 10 | Breakthrough Energy Ventures | Venture capital firm | Paris, France | Energy, Artificial intelligence | Prolific Machines, Type One Energy, Arkea Bio | 6 | 254 | 110 | 9 | In the CSV | ||
| 11 | GO CAPITAL | Private equity firm, Venture capital firm | Rennes, France | Hardware, Health care | Dealt, BIOPHTA, Digital4better | 132 | 52 | 15 | •••@gocapital.fr | +33299••• | In the CSV | |
| 12 | Jeito Capital | Private equity firm | Paris, France | Health care, Biotech | HI-Bio, NMD Pharma, Corteria Pharmaceuticals | 34 | 23 | 4 | In the CSV | |||
| 13 | Partech | Venture capital firm | Paris, France | Hardware, Artificial intelligence | Fresha, OpsMill, Smartness | 5 | 626 | 184 | 117 | •••@partechpartners.com | In the CSV | |
| 14 | Ventech | Venture capital firm | Paris, France | Artificial intelligence, Commerce | Olyzon, Treon | 2 | 231 | 78 | 54 | •••@ventechvc.com | +33 1 ••• | In the CSV |
| 15 | Newfund | Venture capital firm | Paris, France | Artificial intelligence, Hardware | Haiku, Synthpop | 2 | 220 | 103 | 36 | •••@newfundcap.com | In the CSV | |
| 16 | Cathay Capital | Private equity firm, Venture capital firm | Paris, France | Hardware, Health care | Huiying Medical, Qiangua Technology, Avistone Pharmaceuticals | 148 | 75 | 25 | •••@cathay.fr | +33 1 ••• | In the CSV | |
| 17 | Karista | Venture capital firm | Paris, France | Artificial intelligence, Hardware | Incepto Medical, Leanspace | 2 | 146 | 23 | 33 | •••@karista.vc | +33 1 ••• | In the CSV |
| 18 | UI Investissement | Private equity firm | Paris, France | Hardware, Health care | Nova Carbon, Cintoo, Ultrawatt | 101 | 31 | 12 | •••@gmail.com | In the CSV | ||
| 19 | Supernova Invest | Venture capital firm | Paris, France | Hardware, Cybersecurity | Alice & Bob | 1 | 98 | 33 | 8 | •••@supernovainvest.com | +33 (0••• | In the CSV |
| 20 | Mérieux Equity Partners | Private equity firm, Venture capital firm | Lyon, France | Biotech, Health care | Amyl Therapeutics | 1 | 58 | 23 | 20 | •••@merieux-partners.com | +33481••• | In the CSV |
| 21 | IRDI SORIDEC Gestion | Private equity firm, Venture capital firm | Toulouse, France | Hardware, Biotech | Infinite Orbits, IsyBuy, Materrup | 52 | 13 | 1 | •••@irdi.fr | +33-05••• | In the CSV | |
| 22 | IMT Starter | Startup incubator | Évry, France | Artificial intelligence, Biotech | ex9, Echoliv, Welco | 40 | 33 | 6 | •••@telecom-sudparis.eu | +33 1 ••• | In the CSV | |
| 23 | Edmond de Rothschild Private Equity | Private equity firm | Paris, France | Biotech, Health care | Allecra Therapeutics, OncoEthix | 26 | 5 | 15 | +33 1 ••• | In the CSV |
Table 2. Biotech investors in France: the first 23 by recorded investments with a website and a location. Email and phone are masked here and complete in the CSV. Source: FundingWatcher. Data as of 16 November 2026. Base: 23.
Most active in the last 12 months
By portfolio companies funded| # | Investor | Location | Funded, 12 months | Portfolio | Latest |
|---|---|---|---|---|---|
| 1 | Bpifrance | Maisons-alfort, France | 19 | 344 | WORMSENSING, CarbonFarm Technology, Archeon |
| 2 | Kima Ventures | Paris, France | 16 | 325 | Topo.io, Rayon, Kelvin |
| 3 | Breakthrough Energy Ventures | Paris, France | 6 | 30 | Prolific Machines, Type One Energy, Arkea Bio |
| 4 | Sofinnova Partners | Paris, France | 5 | 35 | T-Therapeutics, Mironid, Bon Vivant |
| 5 | Partech | Paris, France | 5 | 132 | Fresha, OpsMill, Smartness |
| 6 | Eurazeo | Paris, France | 4 | 46 | Olyzon, Kohort, Vertical Compute |
| 7 | Elaia | Paris, France | 4 | 69 | Alice & Bob, MyC, Sim&Cure |
| 8 | Seventure Partners | Paris, France | 2 | 45 | Microbiotica, Standing Ovation |
| 9 | Omnes Capital | Paris, France | 2 | 34 | WhiteLab Genomics, BIZAY |
| 10 | Karista | Paris, France | 2 | 24 | Incepto Medical, Leanspace |
| 11 | Newfund | Paris, France | 2 | 59 | Haiku, Synthpop |
| 12 | Ventech | Paris, France | 2 | 43 | Olyzon, Treon |
| 13 | Andera Partners | Paris, France | 2 | 17 | Kainova Therapeutics, Exciva |
| 14 | Mérieux Equity Partners | Lyon, France | 1 | 2 | Amyl Therapeutics |
| 15 | Supernova Invest | Paris, France | 1 | 16 | Alice & Bob |
Table 3. Biotech investors in France: investors in the most companies whose most recent round falls in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Latest rounds in their portfolios
Newest first| Company | What they do | Sector | Location | Last round | Amount | Date | Total raised | Investors on this list | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|
| T-Therapeutics | T-Therapeutics develops T cell receptor therapies, spun off from the University of Cambridge. | Biotech | Cambridge, United Kingdom | Series B | $133.0M | 2026-11-05 | $224.6M | Sofinnova Partners | 51 to 100 | 2022 |
| WORMSENSING | WORMSENSING manufactures hardware, including the world's thinnest piezo ceramic vibration sensor. | Energy | Grenoble, France | Series A | $7.2M | 2026-10-27 | $11.4M | Bpifrance | 11 to 50 | 2020 |
| Microbiotica | Microbiotica develops live bacterial microbiome therapeutics and associated biomarkers. | Biotech | Cambridge, United Kingdom | Series C | $47.9M | 2026-10-16 | $130.7M | Seventure Partners | 11 to 50 | 2016 |
| Prolific Machines | Prolific Machines develops light-controlled gene expression systems for producing therapeutics. | Artificial intelligence | Emeryville, United States | Series B | $50.0M | 2026-10-14 | $147.0M | Breakthrough Energy Ventures | 51 to 100 | 2020 |
| Type One Energy | Type One Energy develops stellarator-based fusion technology for electricity generation. | Energy | Knoxville, United States | Series B | $200.0M | 2026-10-06 | $370.5M | Breakthrough Energy Ventures | 251 to 500 | 2019 |
| Archeon | Archeon develops solutions for monitoring, diagnosing, and treating critically ill patients. | Health care | Besançon, France | Series A | $9.0M | 2026-10-06 | $15.1M | Bpifrance | 11 to 50 | 2018 |
| WhiteLab Genomics | WhiteLab Genomics builds digital tools that help gene and cell therapy companies develop drugs faster and cheaper. | Artificial intelligence | Paris, France | Series B | $26.0M | 2026-10-05 | $36.5M | Omnes Capital | 11 to 50 | 2019 |
| Topo.io | Topo.io builds AI agents for outbound sales that work alongside B2B sales teams. | Software | San Francisco, United States | Seed | $2.5M | 2026-10-04 | $4.1M | Bpifrance, Kima Ventures | 11 to 50 | 2023 |
| Arkea Bio | Arkea Bio develops technology that reduces greenhouse gas emissions from agriculture. | Biotech | Charlestown, United States | Series A | $15.0M | 2026-09-29 | $60.5M | Breakthrough Energy Ventures | 11 to 50 | 2021 |
| Rayon | Rayon provides software for creating architectural drawings. | Software | Paris, France | Series A | $11.4M | 2026-09-23 | $17.6M | Kima Ventures | 11 to 50 | 2021 |
Table 4. Biotech investors in France: the 10 most recent rounds of companies they back. Source: FundingWatcher. Data as of 16 November 2026.
Portfolio sectors
| Portfolio sectors | Companies | Share |
|---|---|---|
| Software | 842 | 74% |
| Artificial intelligence | 220 | 19% |
| Hardware | 182 | 16% |
| Health care | 156 | 14% |
| Fintech | 145 | 13% |
| Commerce | 118 | 10% |
| Biotech | 97 | 9% |
| Cybersecurity | 70 | 6% |
| Education | 49 | 4% |
| Energy | 41 | 4% |
Table 5. Biotech investors in France: portfolio companies by sector. Source: FundingWatcher. Data as of 16 November 2026.
Investment stages
| Investment stages | Investors | Share |
|---|---|---|
| Early stage investors | 21 | 91% |
| Seed investors | 18 | 78% |
| Late stage investors | 15 | 65% |
| Private equity investors | 10 | 43% |
| Venture investors | 10 | 43% |
| Debt investors | 4 | 17% |
| Post IPO investors | 3 | 13% |
| Grant makers | 2 | 9% |
Table 6. Biotech investors in France by stage they invest at. Source: FundingWatcher. Data as of 16 November 2026.
Cities
Table 7. Biotech investors in France by headquarters city. Source: FundingWatcher. Data as of 16 November 2026.
Founded
| Founded | Investors | Share |
|---|---|---|
| 2010s | 5 | 22% |
| 2000s | 7 | 30% |
| 1990s | 4 | 17% |
| 1980s | 2 | 9% |
| 1970s | 1 | 4% |
| 1960s | 2 | 9% |
Table 8. Biotech investors in France by founding decade. Source: FundingWatcher. Data as of 16 November 2026.
Method
- An investor is on this list when it is recorded as an investor in 2 or more funded biotech companies and its headquarters is in France. On 16 November 2026 that is 23 investors.
- 19 rows carry an email address and 17 a phone number from the investor file. Investments, lead investments and exits are the counts the source records.
- The table prints the first 23 rows by recorded investments that carry a website and a location, with email and phone masked. The CSV carries all 23 rows: 0 have no website and 0 no location.
Sources, fields and exclusions of both files: Method.
Questions
- How many biotech investors in France are on the list?
- 23, in the file dated 16 November 2026. 16 of them invested in a company whose most recent round falls in the last 12 months.
- How many have an email address?
- 19 of the 23 carry an email address in the download and 17 a phone number.
- What does the CSV contain?
- One row per investor, 15 columns: name, types, stages, city, region, country, founded, website, linkedin, investments, funded_last_12m, exits, lead_investments, email, phone.
- How much does the list cost?
- $29 one-time for all 23 rows, no account. Every investor and every startup, two files, cost $99. With partner contacts, up to 2 per firm compiled to order and mailed within 24 hours, $199.
- What arrives after payment?
- At once: the CSV with 23 rows, 19 firm email addresses and 17 phone numbers, on the page after payment and by mail. The emails are the address a firm publishes: 13 of the 19 are inboxes such as info@ or contact@. No partner names.
- Can I see rows before buying?
- The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
- How current is the data?
- The file is dated 16 November 2026. The download link serves the current file each time it is opened.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.